

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of T cell differentiation in thymus (GO:0033085) | 6.50947877 |
| 2 | transcytosis (GO:0045056) | 6.36201731 |
| 3 | glucocorticoid biosynthetic process (GO:0006704) | 6.25664815 |
| 4 | chondrocyte proliferation (GO:0035988) | 5.77432858 |
| 5 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.59783168 |
| 6 | cellular glucuronidation (GO:0052695) | 5.28503871 |
| 7 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.09967625 |
| 8 | positive regulation of T cell differentiation in thymus (GO:0033089) | 5.08625755 |
| 9 | cytidine deamination (GO:0009972) | 5.07689303 |
| 10 | cytidine metabolic process (GO:0046087) | 5.07689303 |
| 11 | cytidine catabolic process (GO:0006216) | 5.07689303 |
| 12 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.04310293 |
| 13 | uronic acid metabolic process (GO:0006063) | 4.93955551 |
| 14 | glucuronate metabolic process (GO:0019585) | 4.93955551 |
| 15 | regulation of vitamin metabolic process (GO:0030656) | 4.93264784 |
| 16 | intestinal epithelial cell development (GO:0060576) | 4.82570664 |
| 17 | epithelial cell-cell adhesion (GO:0090136) | 4.60994774 |
| 18 | sperm capacitation (GO:0048240) | 4.58364916 |
| 19 | renal system process involved in regulation of blood volume (GO:0001977) | 4.43741403 |
| 20 | intestinal absorption (GO:0050892) | 4.43673068 |
| 21 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.41478452 |
| 22 | renal filtration (GO:0097205) | 4.34202906 |
| 23 | glomerular filtration (GO:0003094) | 4.31624143 |
| 24 | oligosaccharide biosynthetic process (GO:0009312) | 4.29251194 |
| 25 | negative regulation of macroautophagy (GO:0016242) | 4.23175637 |
| 26 | labyrinthine layer development (GO:0060711) | 4.12862027 |
| 27 | hepatocyte apoptotic process (GO:0097284) | 4.11232584 |
| 28 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.07775215 |
| 29 | positive regulation of respiratory burst (GO:0060267) | 4.04083121 |
| 30 | somite development (GO:0061053) | 4.01616710 |
| 31 | glucocorticoid metabolic process (GO:0008211) | 3.99777324 |
| 32 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.94311750 |
| 33 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.93231711 |
| 34 | lipid translocation (GO:0034204) | 3.89672471 |
| 35 | phospholipid translocation (GO:0045332) | 3.89672471 |
| 36 | positive regulation of epidermis development (GO:0045684) | 3.88387422 |
| 37 | regulation of cholesterol homeostasis (GO:2000188) | 3.86845016 |
| 38 | positive regulation of fatty acid oxidation (GO:0046321) | 3.86819241 |
| 39 | bone resorption (GO:0045453) | 3.85923048 |
| 40 | extracellular matrix assembly (GO:0085029) | 3.85059866 |
| 41 | gap junction assembly (GO:0016264) | 3.76712336 |
| 42 | polyketide metabolic process (GO:0030638) | 3.71465690 |
| 43 | doxorubicin metabolic process (GO:0044598) | 3.71465690 |
| 44 | daunorubicin metabolic process (GO:0044597) | 3.71465690 |
| 45 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.69529117 |
| 46 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.67526107 |
| 47 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.66217222 |
| 48 | regulation of intracellular pH (GO:0051453) | 3.65943367 |
| 49 | regulation of autophagic vacuole assembly (GO:2000785) | 3.64421513 |
| 50 | vitamin A metabolic process (GO:0006776) | 3.64205140 |
| 51 | ethanol oxidation (GO:0006069) | 3.58372770 |
| 52 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.57261335 |
| 53 | endocrine process (GO:0050886) | 3.54224856 |
| 54 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.54224856 |
| 55 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.54224856 |
| 56 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.53460862 |
| 57 | O-glycan processing (GO:0016266) | 3.49704248 |
| 58 | positive regulation of chondrocyte differentiation (GO:0032332) | 3.45567095 |
| 59 | regulation of viral release from host cell (GO:1902186) | 3.44918928 |
| 60 | heterochromatin organization (GO:0070828) | 3.41526252 |
| 61 | drug transmembrane transport (GO:0006855) | 3.40580192 |
| 62 | bile acid and bile salt transport (GO:0015721) | 3.37066496 |
| 63 | hypotonic response (GO:0006971) | 3.34755308 |
| 64 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.34342610 |
| 65 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.33215769 |
| 66 | hemidesmosome assembly (GO:0031581) | 3.32521260 |
| 67 | regulation of cellular pH (GO:0030641) | 3.32502358 |
| 68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.30482053 |
| 69 | negative regulation of anoikis (GO:2000811) | 3.29800085 |
| 70 | negative regulation of myotube differentiation (GO:0010832) | 3.29754171 |
| 71 | regulation of vacuole organization (GO:0044088) | 3.27389421 |
| 72 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.27371246 |
| 73 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.25400122 |
| 74 | positive regulation of pseudopodium assembly (GO:0031274) | 3.23467100 |
| 75 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.23044785 |
| 76 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.22443706 |
| 77 | auditory receptor cell differentiation (GO:0042491) | 3.22134886 |
| 78 | actin filament depolymerization (GO:0030042) | 3.18854966 |
| 79 | notochord development (GO:0030903) | 3.17029757 |
| 80 | one-carbon metabolic process (GO:0006730) | 3.16788606 |
| 81 | regulation of guanylate cyclase activity (GO:0031282) | 3.15512952 |
| 82 | cellular response to vitamin D (GO:0071305) | 3.15393234 |
| 83 | sulfur amino acid catabolic process (GO:0000098) | 3.14889641 |
| 84 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.14048974 |
| 85 | desmosome organization (GO:0002934) | 3.13688881 |
| 86 | regulation of water loss via skin (GO:0033561) | 3.09508205 |
| 87 | smooth muscle tissue development (GO:0048745) | 3.08697660 |
| 88 | intermediate filament organization (GO:0045109) | 3.08216703 |
| 89 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.06889727 |
| 90 | flavonoid metabolic process (GO:0009812) | 3.05736136 |
| 91 | regulation of chemokine secretion (GO:0090196) | 3.04793706 |
| 92 | cGMP-mediated signaling (GO:0019934) | 3.04269464 |
| 93 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.01433488 |
| 94 | regulation of keratinocyte proliferation (GO:0010837) | 2.98945971 |
| 95 | COPI coating of Golgi vesicle (GO:0048205) | 2.97850701 |
| 96 | Golgi transport vesicle coating (GO:0048200) | 2.97850701 |
| 97 | regulation of pH (GO:0006885) | 2.97123467 |
| 98 | embryonic eye morphogenesis (GO:0048048) | 2.96855735 |
| 99 | establishment of skin barrier (GO:0061436) | 2.95152529 |
| 100 | receptor recycling (GO:0001881) | 2.95109129 |
| 101 | regulation of systemic arterial blood pressure (GO:0003073) | 2.93936378 |
| 102 | excretion (GO:0007588) | 2.92176955 |
| 103 | negative regulation of organelle assembly (GO:1902116) | 2.91839932 |
| 104 | Leydig cell differentiation (GO:0033327) | 2.89423261 |
| 105 | keratinocyte development (GO:0003334) | 2.87471730 |
| 106 | drug transport (GO:0015893) | 2.87388055 |
| 107 | sphingomyelin metabolic process (GO:0006684) | 2.87138742 |
| 108 | ethanol metabolic process (GO:0006067) | 2.85359092 |
| 109 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.84872519 |
| 110 | regulation of pseudopodium assembly (GO:0031272) | 2.84475783 |
| 111 | regulation of T cell differentiation in thymus (GO:0033081) | 2.84138699 |
| 112 | regulation of epidermis development (GO:0045682) | 2.82124787 |
| 113 | epithelial structure maintenance (GO:0010669) | 2.81783259 |
| 114 | trophectodermal cell differentiation (GO:0001829) | 2.80569001 |
| 115 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.80396286 |
| 116 | response to hepatocyte growth factor (GO:0035728) | 2.79820309 |
| 117 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.79820309 |
| 118 | hormone catabolic process (GO:0042447) | 2.77629174 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 2.77473103 |
| 120 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.76634778 |
| 121 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.74580066 |
| 122 | regulation of membrane lipid distribution (GO:0097035) | 2.74150743 |
| 123 | negative regulation of epidermis development (GO:0045683) | 2.74001350 |
| 124 | progesterone metabolic process (GO:0042448) | 2.73065712 |
| 125 | sodium ion homeostasis (GO:0055078) | 2.71099708 |
| 126 | * sulfur compound transport (GO:0072348) | 2.70196874 |
| 127 | nucleotide-sugar metabolic process (GO:0009225) | 2.69551170 |
| 128 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.68300509 |
| 129 | positive regulation of cartilage development (GO:0061036) | 2.68209782 |
| 130 | cellular monovalent inorganic cation homeostasis (GO:0030004) | 2.67963412 |
| 131 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.67647281 |
| 132 | vitamin transmembrane transport (GO:0035461) | 2.66551188 |
| 133 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.66071534 |
| 134 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.65717030 |
| 135 | regulation of respiratory burst (GO:0060263) | 2.65504657 |
| 136 | regulation of anoikis (GO:2000209) | 2.64629552 |
| 137 | monovalent inorganic cation homeostasis (GO:0055067) | 2.64261685 |
| 138 | establishment of endothelial barrier (GO:0061028) | 2.64193222 |
| 139 | parturition (GO:0007567) | 2.64033080 |
| 140 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.63730285 |
| 141 | mitotic G2/M transition checkpoint (GO:0044818) | 2.61734476 |
| 142 | regulation of pigment cell differentiation (GO:0050932) | 2.61626725 |
| 143 | thrombin receptor signaling pathway (GO:0070493) | 2.60576254 |
| 144 | regulation of epidermal cell differentiation (GO:0045604) | 2.59769289 |
| 145 | early endosome to late endosome transport (GO:0045022) | 2.59109776 |
| 146 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.58650988 |
| 147 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.58188449 |
| 148 | * sulfate transport (GO:0008272) | 2.57196854 |
| 149 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.57176731 |
| 150 | regulation of fatty acid oxidation (GO:0046320) | 2.56770460 |
| 151 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.56749827 |
| 152 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.56668536 |
| 153 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.55748092 |
| 154 | cell adhesion mediated by integrin (GO:0033627) | 2.55739549 |
| 155 | * sulfate transmembrane transport (GO:1902358) | 2.55629412 |
| 156 | digestive system process (GO:0022600) | 2.54580954 |
| 157 | diol metabolic process (GO:0034311) | 2.53867828 |
| 158 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.53274049 |
| 159 | regulation of cGMP biosynthetic process (GO:0030826) | 2.52792763 |
| 160 | maternal process involved in female pregnancy (GO:0060135) | 2.51617934 |
| 161 | striated muscle atrophy (GO:0014891) | 2.48175939 |
| 162 | regulation of developmental pigmentation (GO:0048070) | 2.47000014 |
| 163 | keratan sulfate catabolic process (GO:0042340) | 2.44291357 |
| 164 | bicarbonate transport (GO:0015701) | 2.43457097 |
| 165 | regulation of collagen biosynthetic process (GO:0032965) | 2.43224362 |
| 166 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.41918367 |
| 167 | angiotensin maturation (GO:0002003) | 2.39268283 |
| 168 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.37925357 |
| 169 | regulation of chondrocyte differentiation (GO:0032330) | 2.37761561 |
| 170 | GDP-mannose metabolic process (GO:0019673) | 2.36147592 |
| 171 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.29456101 |
| 172 | negative regulation of chemokine production (GO:0032682) | 2.27708422 |
| 173 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.27514452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.34884941 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.97005448 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.72280371 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.65029961 |
| 5 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.57634877 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.50603696 |
| 7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.45350615 |
| 8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.45350615 |
| 9 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.45350615 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34672226 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.34276268 |
| 12 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.28908171 |
| 13 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.27879037 |
| 14 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.19571356 |
| 15 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.16148789 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.13675369 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09758915 |
| 18 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.00399883 |
| 19 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.98974738 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94386118 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.92486787 |
| 22 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.84379999 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.83225420 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80021134 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79474293 |
| 26 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.75664811 |
| 27 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.73528417 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73266625 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.72575515 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71818531 |
| 31 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.71492801 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70825390 |
| 33 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.68521822 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68452166 |
| 35 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.66123428 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.65650438 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65038873 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.63592571 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60388886 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.60018580 |
| 41 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.55821827 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54441040 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.54239895 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.54239895 |
| 45 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.52968607 |
| 46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.52118126 |
| 47 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.51458037 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51439475 |
| 49 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50436250 |
| 50 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.49339124 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48691171 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47457365 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.46767823 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46624954 |
| 55 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.45333563 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43606556 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42659978 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41309448 |
| 59 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40465826 |
| 60 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38689123 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34793059 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33736300 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33568299 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33568299 |
| 65 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33166951 |
| 66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32667063 |
| 67 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32598612 |
| 68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29907424 |
| 69 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.27057507 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26758653 |
| 71 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.26452458 |
| 72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25579757 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24994110 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23831771 |
| 75 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.23773394 |
| 76 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.22956001 |
| 77 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20799151 |
| 78 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.19339093 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18595572 |
| 80 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.18522967 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18161345 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18091294 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17446794 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15138198 |
| 85 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.14630722 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14537351 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14519150 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13697278 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13449767 |
| 90 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.12752557 |
| 91 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12750420 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12396042 |
| 93 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11738049 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.11073317 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10968884 |
| 96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10899095 |
| 97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09073061 |
| 98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08974721 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08234401 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07623900 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06963451 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06376432 |
| 103 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05794459 |
| 104 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05699218 |
| 105 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04744060 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04529675 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03643245 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03500989 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02333565 |
| 110 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02318928 |
| 111 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02166513 |
| 112 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01892884 |
| 113 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.01739221 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00909506 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00036103 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99579139 |
| 117 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98052000 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97624663 |
| 119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97551938 |
| 120 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97510672 |
| 121 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97095503 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97058895 |
| 123 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97033129 |
| 124 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.96960435 |
| 125 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.94599823 |
| 126 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94244695 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94129237 |
| 128 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93201853 |
| 129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93163698 |
| 130 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92226685 |
| 131 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91461643 |
| 132 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90348256 |
| 133 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90125006 |
| 134 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89856490 |
| 135 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89251985 |
| 136 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89251985 |
| 137 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89092190 |
| 138 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.88497526 |
| 139 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.88391588 |
| 140 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.86917856 |
| 141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86591852 |
| 142 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85780252 |
| 143 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.84860543 |
| 144 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83729320 |
| 145 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83109927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 6.39758426 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.30559301 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.38230568 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.66216394 |
| 5 | MP0004043_abnormal_pH_regulation | 3.62411056 |
| 6 | MP0003878_abnormal_ear_physiology | 3.15126021 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 3.15126021 |
| 8 | MP0002009_preneoplasia | 2.76483898 |
| 9 | MP0000462_abnormal_digestive_system | 2.72318644 |
| 10 | MP0002822_catalepsy | 2.69677374 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.69379632 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.56666811 |
| 13 | MP0005409_darkened_coat_color | 2.47919603 |
| 14 | MP0003868_abnormal_feces_composition | 2.44834457 |
| 15 | MP0003866_abnormal_defecation | 2.26614926 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.25929401 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.22653450 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 2.10320413 |
| 19 | MP0004147_increased_porphyrin_level | 2.08846357 |
| 20 | MP0002254_reproductive_system_inflammat | 2.07585328 |
| 21 | MP0000490_abnormal_crypts_of | 2.00885817 |
| 22 | MP0010155_abnormal_intestine_physiology | 1.96479585 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.89972061 |
| 24 | MP0001873_stomach_inflammation | 1.86174886 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.79469983 |
| 26 | MP0000477_abnormal_intestine_morphology | 1.76037320 |
| 27 | MP0009379_abnormal_foot_pigmentation | 1.74835304 |
| 28 | MP0003315_abnormal_perineum_morphology | 1.72285258 |
| 29 | MP0009053_abnormal_anal_canal | 1.72094946 |
| 30 | MP0005365_abnormal_bile_salt | 1.60969240 |
| 31 | MP0005381_digestive/alimentary_phenotyp | 1.59476173 |
| 32 | MP0002098_abnormal_vibrissa_morphology | 1.59300274 |
| 33 | MP0004947_skin_inflammation | 1.56691224 |
| 34 | MP0002234_abnormal_pharynx_morphology | 1.54148993 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.50367945 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.49803426 |
| 37 | MP0003045_fibrosis | 1.45874487 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.45739548 |
| 39 | MP0001663_abnormal_digestive_system | 1.44182799 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.40300198 |
| 41 | MP0000762_abnormal_tongue_morphology | 1.40161267 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.37980904 |
| 43 | MP0002796_impaired_skin_barrier | 1.36796780 |
| 44 | MP0000467_abnormal_esophagus_morphology | 1.36274144 |
| 45 | MP0009384_cardiac_valve_regurgitation | 1.34229939 |
| 46 | MP0001849_ear_inflammation | 1.25263642 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.23803699 |
| 48 | MP0005310_abnormal_salivary_gland | 1.21482039 |
| 49 | MP0009840_abnormal_foam_cell | 1.21124893 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.19467705 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.15843862 |
| 52 | MP0000537_abnormal_urethra_morphology | 1.14424294 |
| 53 | * MP0000163_abnormal_cartilage_morphology | 1.11182295 |
| 54 | MP0005670_abnormal_white_adipose | 1.09898943 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.09685174 |
| 56 | MP0001216_abnormal_epidermal_layer | 1.06763546 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.06149874 |
| 58 | MP0003011_delayed_dark_adaptation | 1.05676943 |
| 59 | MP0005508_abnormal_skeleton_morphology | 1.04928727 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04601208 |
| 61 | MP0002282_abnormal_trachea_morphology | 1.03145389 |
| 62 | MP0003436_decreased_susceptibility_to | 1.02391075 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.01353085 |
| 64 | MP0008004_abnormal_stomach_pH | 0.99937199 |
| 65 | MP0006054_spinal_hemorrhage | 0.99815333 |
| 66 | MP0000377_abnormal_hair_follicle | 0.99267428 |
| 67 | MP0004272_abnormal_basement_membrane | 0.98679811 |
| 68 | MP0002060_abnormal_skin_morphology | 0.97778479 |
| 69 | MP0003252_abnormal_bile_duct | 0.96488145 |
| 70 | MP0000516_abnormal_urinary_system | 0.95085538 |
| 71 | MP0005367_renal/urinary_system_phenotyp | 0.95085538 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.94542967 |
| 73 | MP0003937_abnormal_limbs/digits/tail_de | 0.94367982 |
| 74 | MP0000230_abnormal_systemic_arterial | 0.94247258 |
| 75 | MP0005390_skeleton_phenotype | 0.94189408 |
| 76 | MP0004134_abnormal_chest_morphology | 0.93187833 |
| 77 | MP0003941_abnormal_skin_development | 0.93011622 |
| 78 | MP0005360_urolithiasis | 0.91273847 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 0.90999521 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 0.90638685 |
| 81 | MP0001835_abnormal_antigen_presentation | 0.89966490 |
| 82 | MP0006082_CNS_inflammation | 0.89814142 |
| 83 | MP0005501_abnormal_skin_physiology | 0.88580203 |
| 84 | MP0000678_abnormal_parathyroid_gland | 0.87573872 |
| 85 | MP0001879_abnormal_lymphatic_vessel | 0.87435727 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.87109366 |
| 87 | MP0005408_hypopigmentation | 0.87102723 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.86279066 |
| 89 | MP0005023_abnormal_wound_healing | 0.85661581 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.85021545 |
| 91 | MP0005165_increased_susceptibility_to | 0.83720203 |
| 92 | MP0009250_abnormal_appendicular_skeleto | 0.83502722 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.83159947 |
| 94 | MP0000432_abnormal_head_morphology | 0.82954556 |
| 95 | MP0002233_abnormal_nose_morphology | 0.82625696 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.81561688 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.81040126 |
| 98 | MP0005166_decreased_susceptibility_to | 0.80930871 |
| 99 | MP0000613_abnormal_salivary_gland | 0.79817452 |
| 100 | * MP0002115_abnormal_skeleton_extremities | 0.78981890 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.78878735 |
| 102 | * MP0002113_abnormal_skeleton_development | 0.77153172 |
| 103 | * MP0003795_abnormal_bone_structure | 0.76445029 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.76399520 |
| 105 | MP0005275_abnormal_skin_tensile | 0.75559547 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.74264650 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.73132876 |
| 108 | MP0005451_abnormal_body_composition | 0.73072464 |
| 109 | MP0002006_tumorigenesis | 0.72919900 |
| 110 | MP0001664_abnormal_digestion | 0.72850226 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.71704637 |
| 112 | MP0000470_abnormal_stomach_morphology | 0.71426793 |
| 113 | MP0005085_abnormal_gallbladder_physiolo | 0.70748303 |
| 114 | MP0002933_joint_inflammation | 0.70506405 |
| 115 | MP0001881_abnormal_mammary_gland | 0.69277970 |
| 116 | MP0000383_abnormal_hair_follicle | 0.68587832 |
| 117 | MP0000627_abnormal_mammary_gland | 0.68009813 |
| 118 | MP0001756_abnormal_urination | 0.67262517 |
| 119 | MP0003950_abnormal_plasma_membrane | 0.67193457 |
| 120 | MP0005387_immune_system_phenotype | 0.66909286 |
| 121 | MP0001790_abnormal_immune_system | 0.66909286 |
| 122 | MP0009785_altered_susceptibility_to | 0.66219613 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.65774130 |
| 124 | MP0002111_abnormal_tail_morphology | 0.65405670 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.65369909 |
| 126 | MP0002086_abnormal_extraembryonic_tissu | 0.64896795 |
| 127 | MP0002138_abnormal_hepatobiliary_system | 0.64466150 |
| 128 | MP0001191_abnormal_skin_condition | 0.64151605 |
| 129 | MP0003091_abnormal_cell_migration | 0.63705401 |
| 130 | MP0003828_pulmonary_edema | 0.61539914 |
| 131 | MP0004484_altered_response_of | 0.61252174 |
| 132 | MP0000647_abnormal_sebaceous_gland | 0.60708174 |
| 133 | MP0001188_hyperpigmentation | 0.59151829 |
| 134 | MP0003724_increased_susceptibility_to | 0.58393930 |
| 135 | MP0004858_abnormal_nervous_system | 0.57733234 |
| 136 | MP0010771_integument_phenotype | 0.57583229 |
| 137 | MP0000566_synostosis | 0.55263012 |
| 138 | MP0000538_abnormal_urinary_bladder | 0.55192721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased circulating renin level (HP:0003351) | 7.38047950 |
| 2 | Abnormality of renin-angiotensin system (HP:0000847) | 7.08419405 |
| 3 | Cupped ribs (HP:0000887) | 6.73599553 |
| 4 | Hyperaldosteronism (HP:0000859) | 6.18409917 |
| 5 | Abnormality of the 1st metacarpal (HP:0010009) | 5.27420661 |
| 6 | Abnormality of carpal bone ossification (HP:0006257) | 5.25729886 |
| 7 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 5.21951107 |
| 8 | Abnormality of the phalanges of the hallux (HP:0010057) | 4.61783748 |
| 9 | Alkalosis (HP:0001948) | 4.59329988 |
| 10 | Abnormal tarsal ossification (HP:0008369) | 4.47824532 |
| 11 | Hyponatremia (HP:0002902) | 4.43634844 |
| 12 | Abnormality of the 2nd finger (HP:0004100) | 4.39839600 |
| 13 | Abnormal ossification of hand bones (HP:0005921) | 4.30841583 |
| 14 | Abnormal hand bone ossification (HP:0010660) | 4.27898435 |
| 15 | * Abnormality of the distal phalanx of the thumb (HP:0009617) | 4.21500900 |
| 16 | Short phalanx of the thumb (HP:0009660) | 3.99618916 |
| 17 | Posterior subcapsular cataract (HP:0007787) | 3.88170343 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.82267724 |
| 19 | * Flat acetabular roof (HP:0003180) | 3.77377986 |
| 20 | Hypokalemia (HP:0002900) | 3.74300426 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 3.73663757 |
| 22 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.66365416 |
| 23 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.64632690 |
| 24 | Relative macrocephaly (HP:0004482) | 3.61637241 |
| 25 | Abnormality of potassium homeostasis (HP:0011042) | 3.58282500 |
| 26 | Genu varum (HP:0002970) | 3.56525080 |
| 27 | Abnormal biliary tract morphology (HP:0012440) | 3.56083604 |
| 28 | Abnormal foot bone ossification (HP:0010675) | 3.55058207 |
| 29 | Right ventricular cardiomyopathy (HP:0011663) | 3.44151246 |
| 30 | Epiphyseal dysplasia (HP:0002656) | 3.41270473 |
| 31 | Short humerus (HP:0005792) | 3.32339488 |
| 32 | Abnormality of sodium homeostasis (HP:0010931) | 3.31622231 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 3.25841064 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.25841064 |
| 35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.23601439 |
| 36 | Hyperkalemia (HP:0002153) | 3.19679330 |
| 37 | Broad palm (HP:0001169) | 3.18592174 |
| 38 | Coxa vara (HP:0002812) | 3.07260989 |
| 39 | Adrenal overactivity (HP:0002717) | 3.06715924 |
| 40 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 3.02791083 |
| 41 | * Short middle phalanx of finger (HP:0005819) | 3.00853043 |
| 42 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.98993326 |
| 43 | Short femoral neck (HP:0100864) | 2.98283001 |
| 44 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.95807137 |
| 45 | Short hallux (HP:0010109) | 2.94182530 |
| 46 | Hypoplastic ischia (HP:0003175) | 2.91599309 |
| 47 | Renal tubular acidosis (HP:0001947) | 2.87165019 |
| 48 | * Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.83833836 |
| 49 | * Irregular epiphyses (HP:0010582) | 2.78740801 |
| 50 | Delayed epiphyseal ossification (HP:0002663) | 2.78719921 |
| 51 | Flared iliac wings (HP:0002869) | 2.76973005 |
| 52 | Absent phalangeal crease (HP:0006109) | 2.75877677 |
| 53 | Ovoid vertebral bodies (HP:0003300) | 2.73804354 |
| 54 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.70207447 |
| 55 | Hyperactive renin-angiotensin system (HP:0000841) | 2.68647695 |
| 56 | Ileus (HP:0002595) | 2.64769170 |
| 57 | * Abdominal distention (HP:0003270) | 2.62593236 |
| 58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58583975 |
| 59 | Severe short stature (HP:0003510) | 2.57577838 |
| 60 | Short tibia (HP:0005736) | 2.56299618 |
| 61 | Renal salt wasting (HP:0000127) | 2.55919552 |
| 62 | Micronodular cirrhosis (HP:0001413) | 2.54540708 |
| 63 | Subcapsular cataract (HP:0000523) | 2.54240911 |
| 64 | Vitreoretinal degeneration (HP:0000655) | 2.53289566 |
| 65 | Cone-rod dystrophy (HP:0000548) | 2.51787584 |
| 66 | Pili torti (HP:0003777) | 2.50164529 |
| 67 | Focal segmental glomerulosclerosis (HP:0000097) | 2.49271234 |
| 68 | * Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.48382971 |
| 69 | * Abnormality of femoral epiphyses (HP:0006499) | 2.48382971 |
| 70 | Abnormality of the ischium (HP:0003174) | 2.48109325 |
| 71 | Chronic diarrhea (HP:0002028) | 2.43887288 |
| 72 | * Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.42141683 |
| 73 | Dehydration (HP:0001944) | 2.41037254 |
| 74 | Shawl scrotum (HP:0000049) | 2.38697546 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.37839449 |
| 76 | Metaphyseal cupping (HP:0003021) | 2.35616264 |
| 77 | Thin bony cortex (HP:0002753) | 2.33505893 |
| 78 | * Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.31501822 |
| 79 | Rectal prolapse (HP:0002035) | 2.30494570 |
| 80 | * Aplasia/hypoplasia of the femur (HP:0005613) | 2.29821893 |
| 81 | Pustule (HP:0200039) | 2.27551289 |
| 82 | Down-sloping shoulders (HP:0200021) | 2.26988319 |
| 83 | Small epiphyses (HP:0010585) | 2.24726740 |
| 84 | Fat malabsorption (HP:0002630) | 2.23445712 |
| 85 | Hypoplastic iliac wings (HP:0002866) | 2.21817885 |
| 86 | Abnormal finger flexion creases (HP:0006143) | 2.21632054 |
| 87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21477054 |
| 88 | Fragile nails (HP:0001808) | 2.19407491 |
| 89 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.18645741 |
| 90 | Petechiae (HP:0000967) | 2.18255197 |
| 91 | Palpitations (HP:0001962) | 2.17301322 |
| 92 | * Abnormality of the femoral head (HP:0003368) | 2.17061273 |
| 93 | Woolly hair (HP:0002224) | 2.15954169 |
| 94 | * Lumbar hyperlordosis (HP:0002938) | 2.13252556 |
| 95 | * Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 2.12359127 |
| 96 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.12254006 |
| 97 | Villous atrophy (HP:0011473) | 2.12254006 |
| 98 | Cervical subluxation (HP:0003308) | 2.12006029 |
| 99 | Neoplasm of the rectum (HP:0100743) | 2.09440330 |
| 100 | Hyperparathyroidism (HP:0000843) | 2.07094721 |
| 101 | Abnormality of chloride homeostasis (HP:0011422) | 2.05591849 |
| 102 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.05393406 |
| 103 | Protuberant abdomen (HP:0001538) | 2.04578388 |
| 104 | * Hypoplastic ilia (HP:0000946) | 2.03893746 |
| 105 | Tetraparesis (HP:0002273) | 2.02817941 |
| 106 | Enlarged epiphyses (HP:0010580) | 2.01319361 |
| 107 | Milia (HP:0001056) | 2.00556232 |
| 108 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.99946289 |
| 109 | Neoplasm of the small intestine (HP:0100833) | 1.99661088 |
| 110 | Abnormal hair laboratory examination (HP:0003328) | 1.98710650 |
| 111 | Short nail (HP:0001799) | 1.95508603 |
| 112 | Hydroxyprolinuria (HP:0003080) | 1.94878735 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.94878735 |
| 114 | Glomerulosclerosis (HP:0000096) | 1.94721798 |
| 115 | Atrophic scars (HP:0001075) | 1.94047682 |
| 116 | Metaphyseal irregularity (HP:0003025) | 1.92801084 |
| 117 | Syncope (HP:0001279) | 1.92465903 |
| 118 | Cheilitis (HP:0100825) | 1.90217613 |
| 119 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.90011716 |
| 120 | Cardiovascular calcification (HP:0011915) | 1.89203344 |
| 121 | Increased density of long bones (HP:0006392) | 1.88353614 |
| 122 | * Abnormality of the middle phalanges of the hand (HP:0009833) | 1.87996875 |
| 123 | Malnutrition (HP:0004395) | 1.86790627 |
| 124 | Biliary tract neoplasm (HP:0100574) | 1.86787933 |
| 125 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.86389948 |
| 126 | Abnormality of the pubic bones (HP:0003172) | 1.84013350 |
| 127 | Aortic aneurysm (HP:0004942) | 1.83045917 |
| 128 | Vascular calcification (HP:0004934) | 1.82782038 |
| 129 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.82672950 |
| 130 | Autoimmune thrombocytopenia (HP:0001973) | 1.82618083 |
| 131 | * Flat capital femoral epiphysis (HP:0003370) | 1.81054532 |
| 132 | Beaking of vertebral bodies (HP:0004568) | 1.80273226 |
| 133 | Ulnar bowing (HP:0003031) | 1.80207246 |
| 134 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80183376 |
| 135 | Aortic dissection (HP:0002647) | 1.79082716 |
| 136 | Hematochezia (HP:0002573) | 1.77903574 |
| 137 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.76347537 |
| 138 | Hypoplastic scapulae (HP:0000882) | 1.76347537 |
| 139 | Bone pain (HP:0002653) | 1.72255898 |
| 140 | Abnormality of vitamin B metabolism (HP:0004340) | 1.72215144 |
| 141 | Curly hair (HP:0002212) | 1.70449792 |
| 142 | Blepharitis (HP:0000498) | 1.69627775 |
| 143 | Abnormality of the humerus (HP:0003063) | 1.69523756 |
| 144 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.68761764 |
| 145 | Metabolic alkalosis (HP:0200114) | 1.67018335 |
| 146 | * Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.66771999 |
| 147 | Breast hypoplasia (HP:0003187) | 1.65637646 |
| 148 | Abnormality of the fibula (HP:0002991) | 1.65443562 |
| 149 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.65188625 |
| 150 | Tibial bowing (HP:0002982) | 1.63743772 |
| 151 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.62435219 |
| 152 | Symptomatic seizures (HP:0011145) | 1.61849217 |
| 153 | Ankyloglossia (HP:0010296) | 1.61312623 |
| 154 | Hypotension (HP:0002615) | 1.61156991 |
| 155 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.60386478 |
| 156 | Abnormality of vitamin metabolism (HP:0100508) | 1.57306079 |
| 157 | Coarse hair (HP:0002208) | 1.56089914 |
| 158 | Abnormality of the gastric mucosa (HP:0004295) | 1.54154698 |
| 159 | Wormian bones (HP:0002645) | 1.52093758 |
| 160 | Distal lower limb amyotrophy (HP:0008944) | 1.51525332 |
| 161 | Spinal cord lesions (HP:0100561) | 1.51504607 |
| 162 | Syringomyelia (HP:0003396) | 1.51504607 |
| 163 | Amelogenesis imperfecta (HP:0000705) | 1.51449035 |
| 164 | Abnormal pancreas size (HP:0012094) | 1.51190979 |
| 165 | Conjunctival telangiectasia (HP:0000524) | 1.50586017 |
| 166 | Hyperammonemia (HP:0001987) | 1.50179212 |
| 167 | Periodontitis (HP:0000704) | 1.50077585 |
| 168 | Hypoplasia of dental enamel (HP:0006297) | 1.49248240 |
| 169 | Arterial tortuosity (HP:0005116) | 1.48435633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 9.24938824 |
| 2 | ACVR1B | 5.22513885 |
| 3 | MST1R | 4.92289260 |
| 4 | EPHB2 | 3.77109569 |
| 5 | CDK12 | 3.32632598 |
| 6 | PIK3CA | 3.01072269 |
| 7 | STK39 | 2.55332711 |
| 8 | MST4 | 2.29783317 |
| 9 | PDK2 | 2.24940521 |
| 10 | RIPK1 | 2.22634028 |
| 11 | FRK | 2.12327917 |
| 12 | GRK6 | 2.06186374 |
| 13 | PRKG2 | 2.01807067 |
| 14 | MAP2K2 | 1.96508331 |
| 15 | MET | 1.88728281 |
| 16 | ERN1 | 1.83967477 |
| 17 | STK10 | 1.80558274 |
| 18 | DDR2 | 1.72881546 |
| 19 | EPHA2 | 1.71446209 |
| 20 | TGFBR2 | 1.59377864 |
| 21 | MAP3K12 | 1.58751439 |
| 22 | MATK | 1.50409067 |
| 23 | GRK1 | 1.48587649 |
| 24 | PTK6 | 1.41280332 |
| 25 | MAP3K2 | 1.26442636 |
| 26 | MAP3K14 | 1.23763867 |
| 27 | SCYL2 | 1.22181576 |
| 28 | OXSR1 | 1.18969142 |
| 29 | PAK4 | 1.14819914 |
| 30 | TAOK1 | 1.06957358 |
| 31 | LMTK2 | 0.94739504 |
| 32 | CSF1R | 0.93195160 |
| 33 | NUAK1 | 0.90730189 |
| 34 | ICK | 0.89063223 |
| 35 | FGFR3 | 0.88845199 |
| 36 | LATS1 | 0.87435337 |
| 37 | NEK6 | 0.87026614 |
| 38 | PTK2 | 0.86505659 |
| 39 | CSK | 0.86171958 |
| 40 | MAP3K3 | 0.84887988 |
| 41 | TTK | 0.84120773 |
| 42 | TRIB3 | 0.80839198 |
| 43 | ITK | 0.78244629 |
| 44 | BRSK2 | 0.74765024 |
| 45 | SIK1 | 0.72765087 |
| 46 | LATS2 | 0.71209877 |
| 47 | TESK1 | 0.71134220 |
| 48 | CDK9 | 0.70732418 |
| 49 | MAP3K8 | 0.69803082 |
| 50 | MOS | 0.69733877 |
| 51 | CHUK | 0.69362274 |
| 52 | MAPK7 | 0.68275522 |
| 53 | STK3 | 0.68091081 |
| 54 | MAP2K1 | 0.66439272 |
| 55 | ABL2 | 0.66402684 |
| 56 | KSR2 | 0.66365515 |
| 57 | GRK5 | 0.66107652 |
| 58 | CAMK1D | 0.64710159 |
| 59 | NME1 | 0.64270601 |
| 60 | ERBB2 | 0.64232720 |
| 61 | BCR | 0.63495846 |
| 62 | ERBB3 | 0.63310718 |
| 63 | MAPKAPK3 | 0.62324786 |
| 64 | PDPK1 | 0.61273818 |
| 65 | RIPK4 | 0.60808565 |
| 66 | AURKB | 0.60514973 |
| 67 | MAP3K10 | 0.60345371 |
| 68 | RET | 0.59800990 |
| 69 | CAMK2D | 0.59757630 |
| 70 | MAP3K7 | 0.57705628 |
| 71 | CDK7 | 0.55017006 |
| 72 | TYK2 | 0.52698797 |
| 73 | TIE1 | 0.52683729 |
| 74 | NTRK1 | 0.51601105 |
| 75 | DMPK | 0.50390306 |
| 76 | CDK6 | 0.50231162 |
| 77 | RPS6KB2 | 0.50048319 |
| 78 | BMPR2 | 0.49518372 |
| 79 | WNK1 | 0.49208397 |
| 80 | PDGFRB | 0.49185209 |
| 81 | PAK2 | 0.49117998 |
| 82 | PRKAA2 | 0.48796282 |
| 83 | WNK4 | 0.48348843 |
| 84 | NEK9 | 0.48172414 |
| 85 | IKBKB | 0.47436354 |
| 86 | PBK | 0.46600089 |
| 87 | FLT3 | 0.46409214 |
| 88 | NME2 | 0.44787515 |
| 89 | CDC42BPA | 0.44329668 |
| 90 | EIF2AK3 | 0.42682081 |
| 91 | ERBB4 | 0.42650538 |
| 92 | MYLK | 0.41239825 |
| 93 | MAPK11 | 0.40757531 |
| 94 | ADRBK2 | 0.39959341 |
| 95 | JAK1 | 0.38243909 |
| 96 | STK24 | 0.37886563 |
| 97 | EPHB1 | 0.37866264 |
| 98 | GSK3A | 0.37343632 |
| 99 | AKT3 | 0.36128706 |
| 100 | TRPM7 | 0.35406070 |
| 101 | PIM2 | 0.34826389 |
| 102 | MAP3K1 | 0.34486095 |
| 103 | IRAK3 | 0.34247306 |
| 104 | NLK | 0.34024703 |
| 105 | MELK | 0.33518222 |
| 106 | BMX | 0.33385446 |
| 107 | MTOR | 0.32417170 |
| 108 | MAP3K13 | 0.31999989 |
| 109 | PRKCI | 0.31801416 |
| 110 | PDGFRA | 0.31645454 |
| 111 | EEF2K | 0.31575754 |
| 112 | EPHA3 | 0.31324957 |
| 113 | TYRO3 | 0.31323224 |
| 114 | RPS6KA2 | 0.31180887 |
| 115 | TTN | 0.30493297 |
| 116 | MAPKAPK2 | 0.30363318 |
| 117 | IGF1R | 0.29687147 |
| 118 | ZAK | 0.29422746 |
| 119 | AKT2 | 0.28843124 |
| 120 | STK38L | 0.28658436 |
| 121 | YES1 | 0.27865623 |
| 122 | JAK3 | 0.27400065 |
| 123 | NEK2 | 0.27043080 |
| 124 | PDK1 | 0.26907471 |
| 125 | LRRK2 | 0.26292594 |
| 126 | FGFR4 | 0.26017468 |
| 127 | FGFR1 | 0.25272843 |
| 128 | RPS6KB1 | 0.24469675 |
| 129 | SRC | 0.24304169 |
| 130 | EIF2AK2 | 0.24097318 |
| 131 | ADRBK1 | 0.23581107 |
| 132 | PRKCQ | 0.23402821 |
| 133 | FER | 0.23290743 |
| 134 | CLK1 | 0.23241263 |
| 135 | NEK1 | 0.21761360 |
| 136 | MAP3K6 | 0.21303708 |
| 137 | SMG1 | 0.20995387 |
| 138 | PRKACG | 0.19193694 |
| 139 | PKN2 | 0.17869498 |
| 140 | CSNK1A1 | 0.17857797 |
| 141 | SGK3 | 0.17198340 |
| 142 | ROCK1 | 0.16786609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 6.24876264 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.73657908 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 4.03377593 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.98522233 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.51008448 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.42971661 |
| 7 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.19007326 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.08048256 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.06930132 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.97941213 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.91972449 |
| 12 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.90852264 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.82896169 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 1.80712276 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71564532 |
| 16 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.71331971 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.68594928 |
| 18 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.67602834 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.61346445 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52381117 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.50149716 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.46919586 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46355064 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.45116938 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.43957387 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.40562980 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.34741716 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33710852 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31469022 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.25953737 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.25777465 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21291643 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21231174 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20562561 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19546883 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14352339 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.13550685 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.11951776 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11197394 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04846986 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04787117 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.01350141 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00530928 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99996101 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.99303207 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99249420 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95550272 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92668090 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91729259 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89654085 |
| 51 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89494788 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 0.89132305 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.88977155 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88916178 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87095944 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.84992866 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84519558 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84515873 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83974588 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83872664 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82756849 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.81421000 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79267770 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.77568150 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.77548778 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77131363 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77081325 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75205932 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.74791605 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71396527 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71381343 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70282094 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69784847 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69571406 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68236765 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68185751 |
| 77 | Phototransduction_Homo sapiens_hsa04744 | 0.67374470 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.66619066 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65471934 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65378854 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62760539 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62702047 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.62669115 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.61129677 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60422646 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60420888 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60248612 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58682612 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56758843 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56752967 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.56571551 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56117557 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55753805 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.55499969 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55306225 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.53900591 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.53096024 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.52699805 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51138119 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48913780 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48661029 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.47967356 |
| 103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47965892 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47963690 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47667730 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47490432 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47337243 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46519597 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45978149 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.45407673 |
| 111 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45135809 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43991090 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43971830 |
| 114 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43901008 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43540508 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43100751 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42564989 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42518225 |
| 119 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41944278 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40760048 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40460436 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40455331 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40134199 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39999269 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39973047 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.39730602 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39726710 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.39022809 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37480904 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.34438120 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32988507 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29632575 |
| 133 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28004057 |
| 134 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26942583 |
| 135 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26610553 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.25746080 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21998367 |
| 138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.20208691 |
| 139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20000087 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19148561 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.18668885 |
| 142 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18441092 |

